Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vadadustat PK and Safety in CKD Stages 3 and 4
NCT04707573Phase 2Completed
- Sponsor
- Akebia Therapeutics
- Start
- Jul 2010
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of vadadustat in anemia (2 arms), sponsored by Akebia Therapeutics. Primary endpoints: Treatment-emergent Adverse Events, Clinically Significant Changes in Laboratory Parameter Values and 13 more. Started Jul 2010; status: completed.
02
Drugs
vadadustat
03
Conditions
anemia
Beyond the preview
Go deeper on NCT04707573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04707573.